查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813226

2032 年肌肉刺激器市場預測：按產品類型、模式、技術、應用、最終用戶和地區進行的全球分析

Muscle Stimulators Market Forecasts to 2032 - Global Analysis By Product Type, Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球肌肉刺激設備市場預計在 2025 年達到 8.5483 億美元，到 2032 年將達到 11.4781 億美元，預測期內的複合年成長率為 4.3%。

神經肌肉電刺激設備(NMES) 設備，又稱為肌肉刺激器，因其能夠透過受控電脈衝誘發肌肉收縮，在復健和運動科學領域備受關注。其在增強肌肉、促進傷後恢復以及預防固定患者肌肉萎縮方面的效用已得到公認。研究表明，持續、有針對性的刺激可以改善運動功能，促進神經肌肉的再訓練，尤其是在術後和神經系統病例中。然而，最佳化頻率、強度和脈衝持續時間等參數對於確保療效和患者安全至關重要。正在進行的研究旨在改進這些設備，使其能夠應用於更廣泛的臨床和運動領域。

根據世界衛生組織 (WHO) 統計，到 2022 年，全球將有約 17.1 億人患有肌肉骨骼疾病，成為全球首要殘疾原因。僅腰痛一項，就是 160 個國家首要的殘疾原因。

肌肉骨骼疾病盛行率上升

關節炎、背痛和肌肉損傷等肌肉骨骼疾病的發生率不斷上升，是肌肉刺激器市場的主要驅動力。由於這些疾病會損害活動能力並降低生活品質，醫療保健提供者和患者正在尋求非侵入性解決方案來恢復肌肉功能。肌肉刺激器能夠發出定向電脈衝，幫助增強虛弱的肌肉並改善復原效果。研究表明，持續使用可以增強活動能力並加快康復速度。因此，全球肌肉骨骼疾病負擔日益加重，對有效且便捷的復健技術的需求日益強烈，這使得肌肉刺激器成為臨床和家庭環境中的首選治療方案。

設備成本高

肌肉刺激器相對較高的成本嚴重限制了市場擴張，尤其是在新興市場。具有無線功能、應用程式整合或基於人工智慧的客製化功能的先進神經肌肉電刺激 (NMES) 設備需要大量的製造投資，導致最終用戶的價格高昂。對於許多患者和小型診所來說，這些成本可能過高，限制了其普及。此外，對於預算有限的醫院和復健中心來說，高昂的初始投資可能會推遲採購。經濟差距進一步加劇了這個問題，降低了低收入群體的可及性。因此，儘管肌肉刺激器具有臨床益處，但高昂的經濟負擔仍然限制了其普及，並減緩了整體市場的成長。

擴大家庭復健計劃

居家復健計畫發展勢頭強勁，尤其是在新冠疫情之後，這為肌肉刺激器帶來了巨大的成長機會。患者越來越青睞便利、非侵入式且可在遠端監控下獨立進行的療法。肌肉刺激器有助於持續進行有針對性的鍛煉，並減少臨床依賴。研究強調了其在改善術後或固定患者功能恢復和維持肌肉質量方面的有效性。與遠端醫療平台和基於應用程式的指導相結合，可增強可用性和患者參與度。隨著醫療保健系統擴大採用分散式護理模式，家用神經肌肉電刺激 (NMES) 設備的普及率預計將不斷擴大，這將為製造商提供開發易於使用、便攜且互聯互通的解決方案的機會。

副作用和病人安全問題

肌肉刺激器的使用受到潛在副作用的嚴重威脅，這些副作用包括皮膚刺激、肌肉疲勞和刺激不當。不良的患者體驗會降低使用者和臨床醫生的信心，並限制其市場滲透。在家中使用不當且缺乏適當監督會加劇這些擔憂。此外，某些族群（例如患有嚴重神經病變或合併症的患者）的臨床結果並不一致，可能會損害人們對神經肌肉電刺激 (NMES) 有效性的認知。醫療保健提供者可能不願意推薦沒有完善安全規程的設備，監管機構也可能實施更嚴格的指導方針。因此，為了減輕這種威脅，透過病患教育、培訓和設備創新來解決安全問題至關重要。

COVID-19的影響：

新冠疫情對肌肉刺激設備市場產生了雙重影響。一方面，醫院關閉和就診人數減少導致供應鏈暫時中斷，臨床復健服務的可近性受限，導致設備採用率短期內下降。另一方面，疫情加速了向家庭復健和遠端醫療的轉變，為可攜式、易於使用的神經肌肉電刺激 (NMES) 設備創造了新的機會。正在從新冠疫情相關的肌肉無力和長期制動中恢復的患者擴大尋求非侵入性治療方法來恢復力量和活動能力。因此，儘管初期市場活動遭遇挫折，但長期趨勢有利於家庭設備和遠端監控解決方案的成長，凸顯了疫情在該領域發揮的變革性作用。

經皮電刺激 (TENS) 細分市場預計將成為預測期內最大的細分市場

預計經皮神經電刺激 (TENS) 領域將在預測期內佔據最大的市場佔有率。這一成長主要得益於 TENS 在非侵入性疼痛管理中的廣泛應用，可有效緩解關節炎、下背痛和肌肉痛等症狀。 TENS 的易用性、價格實惠以及臨床和家庭適用性進一步推動了其受歡迎程度。慢性疼痛疾病的盛行率不斷上升以及人們對非藥物治療方法的日益青睞，是 TENS 佔據市場領先地位的重要因素。隨著醫療保健系統日益重視非藥物療法，TENS 繼續受到患者和醫療服務提供者的青睞。

疼痛管理領域預計將在預測期內以最高的複合年成長率成長

預計疼痛管理領域將在預測期內實現最高成長率。這一成長主要源於關節炎和腰痛等慢性疼痛疾病的日益流行，以及人們對非侵入性、無藥物治療方案的日益青睞。肌肉刺激器，尤其是經皮神經電刺激 (TENS) 設備，在尋求有效緩解疼痛且避免藥物治療副作用的患者中越來越受歡迎。此外，設備技術的進步，包括便攜性和方便用戶使用介面的改進，進一步促進了該領域的擴張，從而提高了患者的依從性和滿意度。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。這項優勢歸功於多種因素，包括先進的醫療基礎設施、肌肉骨骼和神經系統疾病的高發病率以及創新醫療技術的廣泛應用。美國尤其憑藉其在醫療保健研發方面的巨額投資、醫療設備的高利用率以及支持使用先進肌肉刺激設備的完善醫療保健體系，引領市場。此外，患者和醫療服務提供者對疼痛管理和復健療法的認知不斷提高，也有助於該地區鞏固市場領導地位。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。這一成長的主要驅動力包括人們的健康意識不斷增強、疼痛管理療法的普及以及用於維護健康的智慧型裝置的使用日益增多。此外，該地區運動傷害的激增，進一步刺激了對肌肉刺激設備的需求。印度等國家預計將實現顯著成長，這得益於其不斷擴大的醫療基礎設施以及大量尋求非侵入性治療方案的患者。這些因素共同使亞太地區成為肌肉刺激設備成長最快的區域市場。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球肌肉刺激器市場（依產品類型）

  • 經皮電刺激（TENS）
  • 功能性電刺激（FES）
  • 電肌肉刺激（EMS）
  • 神經肌肉電刺激（NMES）

6. 全球肌肉刺激設備市場（按模式）

  • 可攜式/桌上型系統
  • 手持裝置

7. 全球肌肉刺激設備市場（依技術）

  • 模擬
  • 數位的
  • 無線/智慧整合

第8章全球肌肉刺激器市場（按應用）

  • 疼痛管理
  • 復原
  • 肌肉強化
  • 提升運動表現

9. 全球肌肉刺激器市場（按最終用戶）

  • 醫院
  • 物理治療診所
  • 居家醫療
  • 運動診所/運動中心

第 10 章全球肌肉刺激器市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第 12 章：公司概況

  • Abbott Laboratories
  • AxioBionics
  • Beurer
  • BioMedical Life Systems
  • BTL
  • Chattanooga（DJO）
  • Compex
  • EMS Physio
  • Enovis Corporation（DJO）
  • GAMA Healthcare
  • Globus Corporation
  • Ito Physiotherapy & Rehabilitation
  • Liberate Medical
  • Mettler Electronics
  • NeuroMetrix
Product Code: SMRC30685

According to Stratistics MRC, the Global Muscle Stimulators Market is accounted for $854.83 million in 2025 and is expected to reach $1147.81 million by 2032 growing at a CAGR of 4.3% during the forecast period. Muscle stimulators, or neuromuscular electrical stimulation (NMES) devices, have garnered significant attention in rehabilitation and sports science for their ability to evoke muscle contractions through controlled electrical impulses. As a research associate, I recognize their utility in enhancing muscle strength, accelerating recovery after injury, and preventing atrophy in immobilized patients. Studies indicate that consistent, targeted stimulation can improve motor function and facilitate neuromuscular re-education, particularly in post-operative or neurological cases. However, optimizing parameters such as frequency, intensity, and pulse duration is critical to ensure efficacy and patient safety. Ongoing investigations aim to refine these devices for broader clinical and athletic applications.

According to the World Health Organization (WHO), in 2022, approximately 1.71 billion people globally were affected by musculoskeletal conditions, making them the leading cause of disability worldwide. Low back pain alone was the top cause of disability in 160 countries.

Market Dynamics:

Driver:

Rising prevalence of musculoskeletal disorders

The increasing incidence of musculoskeletal disorders, such as arthritis, back pain, and muscle injuries, is a significant driver for the muscle stimulators market. As these conditions impair mobility and reduce quality of life, healthcare providers and patients seek non-invasive solutions to restore muscle function. Muscle stimulators offer targeted electrical impulses that aid in strengthening weakened muscles and improving rehabilitation outcomes. Studies have shown that consistent use enhances motor function and accelerates recovery. Consequently, the growing burden of musculoskeletal conditions globally creates a strong demand for effective and convenient rehabilitation technologies, positioning muscle stimulators as a preferred therapeutic solution in clinical and home settings.

Restraint:

High device costs

The relatively high cost of muscle stimulators is a major restraint for market expansion, particularly in developing regions. Advanced NMES devices with wireless capabilities, app integration, or AI-based customization require significant manufacturing investment, which translates to higher prices for end-users. Many patients and smaller clinics may find these costs prohibitive, limiting adoption. Additionally, high initial investments can slow procurement in hospitals or rehabilitation centers, where budgets are constrained. Economic disparities further exacerbate this issue, reducing accessibility in low-income populations. Consequently, despite their clinical benefits, the financial burden associated with muscle stimulators continues to restrict widespread uptake and slows overall market growth.

Opportunity:

Expansion of home-based rehabilitation programs

Home-based rehabilitation programs have gained momentum, particularly after the COVID-19 pandemic, presenting a substantial growth opportunity for muscle stimulators. Patients increasingly prefer convenient, non-invasive therapies that can be administered independently under remote supervision. Muscle stimulators facilitate consistent, targeted exercise, reducing dependency on clinical visits. Research underscores their effectiveness in improving functional recovery and maintaining muscle mass in post-operative or immobilized patients. Integration with telehealth platforms and app-based guidance enhances usability and patient engagement. As healthcare systems increasingly embrace decentralized care models, the adoption of home-use NMES devices is poised to grow, offering manufacturers opportunities to develop user-friendly, portable, and connected solutions.

Threat:

Side effects and patient safety concerns

The use of muscle stimulators is seriously threatened by possible side effects, such as skin irritation, muscle fatigue, or inappropriate stimulation. Negative patient experiences can reduce confidence among users and clinicians, limiting market penetration. Misuse at home without adequate supervision can exacerbate these concerns. Additionally, inconsistent clinical outcomes in specific populations, such as patients with severe neurological deficits or comorbidities, may undermine the perceived efficacy of NMES. Healthcare providers may hesitate to recommend devices without robust safety protocols, and regulatory authorities may impose stricter guidelines. Addressing safety concerns through patient education, training, and device innovation is therefore critical to mitigating this threat.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the muscle stimulators market. On one hand, lockdowns and reduced hospital visits temporarily disrupted supply chains and limited access to clinical rehabilitation services, causing short-term declines in device adoption. On the other hand, the pandemic accelerated the shift toward home-based rehabilitation and telehealth, creating new opportunities for portable and user-friendly NMES devices. Patients recovering from COVID-19-related muscle weakness or prolonged immobilization increasingly sought non-invasive therapies to restore strength and mobility. Consequently, while initial market activity faced setbacks, the long-term trend favored growth in home-use devices and remote monitoring solutions, highlighting the pandemic's transformative effect on the sector.

The transcutaneous electrical nerve stimulation (TENS) segment is expected to be the largest during the forecast period

The transcutaneous electrical nerve stimulation (TENS) segment is expected to account for the largest market share during the forecast period. This prominence is primarily attributed to TENS's widespread application in non-invasive pain management, offering effective relief for conditions such as arthritis, back pain, and muscle soreness. Its popularity is further bolstered by its ease of use, affordability, and suitability for both clinical and home settings. The increasing prevalence of chronic pain disorders and a growing preference for drug-free therapeutic options have significantly contributed to TENS's market leadership. As healthcare systems emphasize non-pharmacological treatments, TENS continues to be a preferred choice among patients and healthcare providers alike.

The pain management segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pain management segment is predicted to witness the highest growth rate. This growth is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis and back pain, and a growing preference for non-invasive, drug-free therapeutic options. Muscle stimulators, particularly Transcutaneous Electrical Nerve Stimulation (TENS) devices, have gained popularity among patients seeking effective pain relief without the side effects associated with pharmacological treatments. Furthermore, the segment's expansion is further supported by advancements in device technology, including portability and user-friendly interfaces, which enhance patient compliance and satisfaction.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This dominance is attributed to several factors, including advanced healthcare infrastructure, high prevalence of musculoskeletal and neurological disorders, and strong adoption of innovative medical technologies. The United States, in particular, leads the market due to substantial investments in healthcare research and development, a high rate of medical device utilization, and a well-established healthcare system that supports the use of advanced muscle stimulators. Additionally, the growing awareness of pain management and rehabilitation therapies among patients and healthcare providers further contributes to the region's leading position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This growth is primarily driven by increasing awareness of health and wellness, a rising adoption of pain management treatments, and the growing use of smart devices for maintaining health. Additionally, the region is witnessing a surge in sports-related injuries, further fueling the demand for muscle stimulators. Countries like India are expected to register significant growth due to expanding healthcare infrastructure and a large patient population seeking non-invasive therapeutic solutions. The combination of these factors positions Asia Pacific as the fastest-growing regional market for muscle stimulators.

Key players in the market

Some of the key players in Muscle Stimulators Market include Abbott Laboratories, AxioBionics, Beurer, BioMedical Life Systems, BTL, Chattanooga (DJO), Compex, EMS Physio, Enovis Corporation (DJO), GAMA Healthcare, Globus Corporation, Ito Physiotherapy & Rehabilitation, Liberate Medical, Mettler Electronics and NeuroMetrix.

Key Developments:

In February 2025, Globus Medical and Nevro Corp. announced they have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement, which was unanimously approved by the boards of directors of both companies, Globus Medical will acquire all shares of Nevro for $5.85 per share.

In December 2024, Abbott Laboratories and DexCom said they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.

In October 2024, PT Beurer Indonesia Technology, a subsidiary of German healthcare device manufacturer Beurer GmbH, has opened a factory at the Kendal Special Economic Zone (KEK) in Central Java, making it the first such production facility in Southeast Asia. The company's decision to expand to Indonesia was formalized, when Beurer signed an investment agreement with KEK Kendal at the Hannover Messe event in Germany.

Product Types Covered:

  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Functional Electrical Stimulation (FES)
  • Electrical Muscle Stimulation (EMS)
  • Neuromuscular Electrical Stimulation (NMES)

Modalities Covered:

  • Portable/Bench-top Systems
  • Handheld Devices

Technologies Covered:

  • Analog
  • Digital
  • Wireless / Smart-integrated

Applications Covered:

  • Pain Management
  • Rehabilitation
  • Muscle Strengthening
  • Athletic Performance Enhancement

End Users Covered:

  • Hospitals
  • Physiotherapy Clinics
  • Home Care Settings
  • Sports Clinics / Athletic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Muscle Stimulators Market, By Product Type

  • 5.1 Introduction
  • 5.2 Transcutaneous Electrical Nerve Stimulation (TENS)
  • 5.3 Functional Electrical Stimulation (FES)
  • 5.4 Electrical Muscle Stimulation (EMS)
  • 5.5 Neuromuscular Electrical Stimulation (NMES)

6 Global Muscle Stimulators Market, By Modality

  • 6.1 Introduction
  • 6.2 Portable/Bench-top Systems
  • 6.3 Handheld Devices

7 Global Muscle Stimulators Market, By Technology

  • 7.1 Introduction
  • 7.2 Analog
  • 7.3 Digital
  • 7.4 Wireless / Smart-integrated

8 Global Muscle Stimulators Market, By Application

  • 8.1 Introduction
  • 8.2 Pain Management
  • 8.3 Rehabilitation
  • 8.4 Muscle Strengthening
  • 8.5 Athletic Performance Enhancement

9 Global Muscle Stimulators Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Physiotherapy Clinics
  • 9.4 Home Care Settings
  • 9.5 Sports Clinics / Athletic Centers

10 Global Muscle Stimulators Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 AxioBionics
  • 12.3 Beurer
  • 12.4 BioMedical Life Systems
  • 12.5 BTL
  • 12.6 Chattanooga (DJO)
  • 12.7 Compex
  • 12.8 EMS Physio
  • 12.9 Enovis Corporation (DJO)
  • 12.10 GAMA Healthcare
  • 12.11 Globus Corporation
  • 12.12 Ito Physiotherapy & Rehabilitation
  • 12.13 Liberate Medical
  • 12.14 Mettler Electronics
  • 12.15 NeuroMetrix

List of Tables

  • Table 1 Global Muscle Stimulators Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Muscle Stimulators Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Muscle Stimulators Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2024-2032) ($MN)
  • Table 4 Global Muscle Stimulators Market Outlook, By Functional Electrical Stimulation (FES) (2024-2032) ($MN)
  • Table 5 Global Muscle Stimulators Market Outlook, By Electrical Muscle Stimulation (EMS) (2024-2032) ($MN)
  • Table 6 Global Muscle Stimulators Market Outlook, By Neuromuscular Electrical Stimulation (NMES) (2024-2032) ($MN)
  • Table 7 Global Muscle Stimulators Market Outlook, By Modality (2024-2032) ($MN)
  • Table 8 Global Muscle Stimulators Market Outlook, By Portable/Bench-top Systems (2024-2032) ($MN)
  • Table 9 Global Muscle Stimulators Market Outlook, By Handheld Devices (2024-2032) ($MN)
  • Table 10 Global Muscle Stimulators Market Outlook, By Technology (2024-2032) ($MN)
  • Table 11 Global Muscle Stimulators Market Outlook, By Analog (2024-2032) ($MN)
  • Table 12 Global Muscle Stimulators Market Outlook, By Digital (2024-2032) ($MN)
  • Table 13 Global Muscle Stimulators Market Outlook, By Wireless / Smart-integrated (2024-2032) ($MN)
  • Table 14 Global Muscle Stimulators Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Muscle Stimulators Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 16 Global Muscle Stimulators Market Outlook, By Rehabilitation (2024-2032) ($MN)
  • Table 17 Global Muscle Stimulators Market Outlook, By Muscle Strengthening (2024-2032) ($MN)
  • Table 18 Global Muscle Stimulators Market Outlook, By Athletic Performance Enhancement (2024-2032) ($MN)
  • Table 19 Global Muscle Stimulators Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global Muscle Stimulators Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 21 Global Muscle Stimulators Market Outlook, By Physiotherapy Clinics (2024-2032) ($MN)
  • Table 22 Global Muscle Stimulators Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 23 Global Muscle Stimulators Market Outlook, By Sports Clinics / Athletic Centers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.